These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 37708585)

  • 1. Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey.
    Ferguson M; Sedgemore KO; Scow M; Choisil P; Haywood B; Xavier J; Crabtree A; Stitilis B; Liu L; Buxton JA
    Int J Drug Policy; 2023 Oct; 120():104186. PubMed ID: 37708585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying early intervention opportunities for illicit stimulant use: A cross-sectional study of factors associated with illicit stimulant use among young people accessing integrated youth services in British Columbia, Canada.
    Kreim S; Marchand K; Mallia E; Dubras R; McMaster WR; Tee K; Mathias S; Barbic S
    J Subst Use Addict Treat; 2023 Aug; 151():209076. PubMed ID: 37182544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
    Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada.
    Papamihali K; Yoon M; Graham B; Karamouzian M; Slaunwhite AK; Tsang V; Young S; Buxton JA
    Harm Reduct J; 2020 Nov; 17(1):90. PubMed ID: 33228676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use to manage stimulant cravings among people who use unregulated drugs.
    Reddon H; Socias ME; DeBeck K; Hayashi K; Walsh Z; Milloy MJ
    Addict Behav; 2024 Jan; 148():107867. PubMed ID: 37748225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia.
    Kamal A; Ferguson M; Xavier JC; Liu L; Graham B; Lock K; Buxton JA
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):27. PubMed ID: 37194018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services.
    Papamihali K; Collins D; Karamouzian M; Purssell R; Graham B; Buxton J
    PLoS One; 2021; 16(5):e0252090. PubMed ID: 34038452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.
    Urbanoski KA; van Roode T; Selfridge M; Hogan KC; Fraser J; Lock K; McGreevy PB; Burmeister C; Barker B; Slaunwhite A; Nosyk B; Pauly B
    Subst Abuse Treat Prev Policy; 2024 Sep; 19(1):44. PubMed ID: 39285270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
    Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
    Steinberg A; Mehta A; Papamihali K; Lukac CD; Young S; Graham B; Lock K; Fleury M; Buxton JA
    BMJ Open; 2022 May; 12(5):e060447. PubMed ID: 35501101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of prescription stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender minorities who have sex with men.
    Westmoreland DA; Goldshear JL; Carrico AW; Grov C
    Drug Alcohol Depend; 2021 Sep; 226():108841. PubMed ID: 34271513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking the line: stimulant use during sex and HIV risk behavior among Black urban MSM.
    Mimiaga MJ; Reisner SL; Fontaine YM; Bland SE; Driscoll MA; Isenberg D; Cranston K; Skeer MR; Mayer KH
    Drug Alcohol Depend; 2010 Jul; 110(1-2):30-7. PubMed ID: 20334986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Marchand K; Peachey GS; Westfall J; Lock K; MacDonald S; Jun J; Bojanczyk-Shibata A; Harrison S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):68. PubMed ID: 34530878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
    Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
    Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
    Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
    Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards cross-Canada monitoring of the unregulated street drug supply.
    Biggar E; Papamihali K; Leclerc P; Hyshka E; Graham B; Taylor M; Payer D; Maloney-Hall B; Buxton JA
    BMC Public Health; 2021 Sep; 21(1):1678. PubMed ID: 34525994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.